Evercore Wealth Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,260
Closed -$387K 367
2019
Q4
$387K Sell
10,260
-25,335
-71% -$1.14M 0.01% 312
2019
Q3
$1.66M Sell
35,595
-14,529
-29% -$675K 0.05% 164
2019
Q2
$2.62M Sell
50,124
-159,823
-76% -$9.37M 0.08% 131
2019
Q1
$14.5M Buy
209,947
+18,672
+10% +$1.25M 0.47% 51
2018
Q4
$11.4M Sell
191,275
-74,130
-28% -$6.4M 0.43% 52
2018
Q3
$30.7M Buy
265,405
+2,296
+0.9% +$259K 0.98% 38
2018
Q2
$33.2M Buy
263,109
+14,983
+6% +$1.82M 1.13% 33
2018
Q1
$26.9M Sell
248,126
-2,780
-1% -$308K 1.03% 34
2017
Q4
$27.5M Buy
250,906
+18,069
+8% +$1.8M 1.02% 35
2017
Q3
$23M Sell
232,837
-8,297
-3% -$804K 0.9% 38
2017
Q2
$24.4M Sell
241,134
-11,731
-5% -$1.26M 0.94% 39
2017
Q1
$29.2M Buy
252,865
+4,435
+2% +$515K 1.14% 35
2016
Q4
$29.8M Sell
248,430
-486
-0.2% -$53.8K 1.24% 30
2016
Q3
$28M Buy
248,916
+22,146
+10% +$2.55M 1.16% 33
2016
Q2
$28.1M Buy
226,770
+3,115
+1% +$376K 1.24% 30
2016
Q1
$25.1M Buy
223,655
+31,742
+17% +$3.3M 1.11% 32
2015
Q4
$20.9M Buy
191,913
+13,343
+7% +$1.53M 0.97% 37
2015
Q3
$17.8M Buy
178,570
+32,017
+22% +$3.48M 0.85% 41
2015
Q2
$16.7M Buy
146,553
+12,147
+9% +$1.47M 0.75% 44
2015
Q1
$14M Buy
134,406
+131,392
+4,359% +$14M 0.64% 50
2014
Q4
$363K Sell
3,014
-86
-3% -$11.3K 0.02% 291
2014
Q3
$454K Sell
3,100
-200
-6% -$30.9K 0.02% 275
2014
Q2
$551K Hold
3,300
0.03% 258
2014
Q1
$655K Sell
3,300
-75
-2% -$14.2K 0.04% 227
2013
Q4
$644K Hold
3,375
0.04% 233
2013
Q3
$572K Sell
3,375
-125
-4% -$19.4K 0.03% 263
2013
Q2
$530K Buy
+3,500
New +$496K 0.03% 271

Other funds holding CLB

Evercore Wealth Management's CLB Position: Q1 2020 in Review

Evercore Wealth Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 10,260 shares — an estimated $387K sold.

Evercore Wealth Management first reported a position in CLB in Q2 2013 and held it in 27 quarters. The position peaked at $33.2M in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Evercore Wealth Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Evercore Wealth Management sold 10,260 Core Laboratories shares in Q1 2020, an estimated $387K.
  • Evercore Wealth Management first reported a position in Core Laboratories in Q2 2013 and held it in 27 quarters.
  • Evercore Wealth Management's Core Laboratories position peaked at $33.2M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Evercore Wealth Management's 13F filing for Q1 2020, filed 14 May 2020.